We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
GlaxoSmithKline Pharmaceuticals Limited is expanding its clinical trial data
management, analyses and reporting activities in India where it plans to double
the headcount depending on business needs.
Diatos S.A., a privately held biopharmaceutical company, announced today the
expansion of its operations with the opening of a new subsidiary, Diatos USA,
Inc., with business offices located on the West Coast of the United States.
Elan said Monday that U.S. regulators were investigating
trades in the pharmaceutical company's shares immediately before they plummeted
over the surprise withdrawal of a top new drug.
Although South Africa's existing Patent Act nominally affords patents
a lifespan of 20 years, with payment of a renewal fee every three years, the
country's intellectual property regime has continued to attract criticism.
Brazil's government has reportedly allowed a three-day extension
to negotiations for voluntary licensing of the HIV/AIDS drugs Tenofovir, Efavirenz
and the Lopinavir/Ritonavir combination therapy.
India's government has warned that it could retaliate against measures
by the European Union (EU) to cut imports of drug products such as wide-spectrum
antibiotics under the so-called advanced licence scheme.
A group of economists, public health experts and lawyers has proposed a way
to convince drug companies to develop lifesaving vaccines for poor countries,
where market demand is weak and profits low.